JPRN-UMIN000036126已完成未知
Effects of alkalization therapy in metastatic or recurrent pancreatic cancer: a case-control study - Effects of alkalization therapy in metastatic or recurrent pancreatic cancer
Karasuma Wada Clinic0 个研究点目标入组 125 人开始时间: 2019年3月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who refused to participate the study by opt-out.
研究者
相似试验
招募中
Unknown
The impact of alkalization therapy on cancer treatment: a retrospective observational studyJPRN-UMIN000052333Japanese Society on Inflammation and Metabolism in Cancer2,000
已完成
不适用
Effects of combination of alkalization therapy plus intravenous vitamin C treatment on chemotherapy outcomes in small cell lung cancer, retrospective studySmall cell lung cancerJPRN-UMIN000043056Japanese Society on Inflammation and Metabolism in Cancer33
进行中（未招募）
不适用
Study on intensive chemotherapy in patients with breast cancer with 1 to 3 metastatic lesions. The breast tumor has to be hormonal receptor negative and HER2 negative.EUCTR2011-001237-16-NLKI-AV
撤回
2 期
High-dose alkylating chemotherapy in oligo-metastatic breast cancer harboring homologous recombination deficiencymammary neoplasms10006291breast cancerNL-OMON36155ederlands Kanker Instituut100
进行中（未招募）
1 期
Study on intensive chemotherapy in patients with breast cancer with 1 to 3 metastatic lesions. The breast tumor has to harbor homologous recombination deficiencyOligo metastatic breast cancer harboring homologous recombination deficiency and/or the patient has a deleterious germline BRCA1 or BRCA2 mutationMedDRA version: 20.1 Level: PT Classification code 10055113 Term: Breast cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-000838-19-NLKI-AV74